Related Experiment Video
Updated: Jun 9, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Proteomic Profile of the ICAM1 p.K56M HFpEF Risk Variant.
Pedro Giro1, Mallory Filipp2, Michael J Zhang3
1Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
A common ICAM1 variant (rs5491) is linked to heart failure with preserved ejection fraction (HFpEF) in African Americans. This study identifies inflammatory proteins and pathways associated with this genetic risk factor.
Area of Science:
- Genetics
- Cardiovascular Disease
- Proteomics
Background:
- A common missense variant in ICAM1 (rs5491; pK56M) is associated with heart failure with preserved ejection fraction (HFpEF) risk in African Americans.
- The specific biological pathways linking this variant to HFpEF remain unclear.
Purpose of the Study:
- To investigate the circulating proteomic networks associated with the ICAM1 rs5491 variant.
- To identify inflammatory pathways potentially driving HFpEF in African Americans carrying the rs5491 variant.
Main Methods:
- Analysis of 92 circulating proteins and their networks in over 600 African American individuals.
- Weighted gene co-expression network analysis to identify protein networks associated with rs5491.
- Validation of the inflammatory proteomic profile in a separate cohort.
Main Results:
- Seven circulating inflammatory proteins were associated with the rs5491 variant.
- One protein network, enriched with tumor necrosis receptor superfamily members, was significantly associated with rs5491.
- The rs5491 variant showed a consistent inflammatory proteomic profile across cohorts.
Conclusions:
- Inflammatory pathways, particularly those involving the tumor necrosis receptor superfamily, are implicated in HFpEF pathogenesis in African Americans with the ICAM1 rs5491 variant.
- This research provides insight into the molecular mechanisms underlying genetic risk for HFpEF.
More Related Videos
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
12:50Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017